Related Experiment Video
Updated: May 10, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Measurement of hepatic venous pressure gradient is feasible and safe in children
Jessica Woolfson1, Philip John, Binita Kamath
1*Division of Gastroenterology, Hepatology, and Nutrition †Department of Paediatrics, University of Toronto ‡Division of Interventional Radiology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
Hepatic venous pressure gradient (HVPG) measurement is safe and feasible in pediatric patients with severe liver disease. This study assessed the safety and feasibility of HVPG in children, finding no complications.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Interventional Radiology
Background:
- Hepatic venous pressure gradient (HVPG) is a key metric for assessing portal hypertension in adults.
- Data on HVPG measurement in pediatric populations is limited.
- Understanding HVPG in children is crucial for managing liver disease.
Purpose of the Study:
- To evaluate the feasibility of performing HVPG measurements in children.
- To assess the safety profile of HVPG measurements in pediatric patients.
- To establish baseline HVPG values in a pediatric cohort.
Main Methods:
- Retrospective review of 49 pediatric patients undergoing HVPG measurement between 2000 and 2011.
- Data collected included clinical details, procedural information, and outcomes.
- Analysis of HVPG values and complication rates.
Main Results:
- 52 HVPG measurements were performed in 49 children (mean age 8.2 years).
- Diagnoses varied, including acute liver failure, cirrhosis, and post-transplant states.
- No complications were reported; HVPG values ranged from 0-28 mmHg, with 30 patients showing elevated levels (>6 mmHg).
Conclusions:
- HVPG measurement is a feasible and safe procedure in children with severe liver disease.
- Further research is needed to define the clinical utility of HVPG in pediatric portal hypertension and acute liver conditions.
Background And Objectives:
Hepatic venous pressure gradient (HVPG) is an indirect measure of portal venous pressure in cirrhosis, which is valid in cirrhotic adults for evaluating the severity of portal hypertension, predicting outcomes, and guiding therapeutic decisions. Published data on the measurement of HVPG in children are sparse. The aim of the present study was to determine the feasibility and safety of undertaking HVPG measurements in children.
Methods:
Children who underwent HVPG measurements between 2000 and 2011 were identified from our interventional radiology database. Medical charts were reviewed for clinical, procedural, and outcome data.
Results:
A total of 49 patients (25 boys, mean age 8.2 ± 5.6 years) underwent 52 HVPG measurements. Diagnoses included cirrhosis (n = 7), acute liver failure (n = 15), postliver transplant (n = 6), postbone marrow transplant (n = 9), vascular anomalies (n = 3), and others (n = 9). There were no complications related to HVPG measurement. HVPG values ranged between 0 and 28 mmHg, median 9.0 (range 0-28) mmHg, and were elevated >6 mmHg in 30 patients.
Conclusions:
HVPG measurement is feasible and safe in children with severe liver disease. The clinical use of HVPG measurements in managing children with portal hypertension or with acute liver diseases must now be determined.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pre-Procedural Guidelines for Assessing Blood Pressure

